Skip to content
QuantMundi
NetherlandsNetherlands·Stock·Euronext Brussels

argenx SE (ARGX.BR)

Health Care · Biotechnology · Europe

Optimize with this asset

Price in EUR, last 5 years

Last price
€795.40 (Oct 22, 2026)
1-year return
+12.2%
3-year annual return
+20.6%
5-year annual return
+26.1%
1-year volatility
39.5%
Max drawdown (5Y)
-39.3%
Market cap (approx.)
US$56.1B
History available
since Jul 10, 2014

About argenx SE

argenx SE (ARGX.BR) is a stock from the Netherlands that trades on Euronext Brussels in EUR. It operates in the health care sector, Biotechnology industry. It's part of the Euro Stoxx 50.

Over the last year its price rose 12.2% in EUR, with annual volatility of 40%: a quite volatile asset. Its worst drop over the last five years was 39.3% from a peak.

If your currency isn't the EUR, your real return will also depend on the exchange rate. In the optimizer you can choose your currency (USD, EUR, MXN, BRL, CLP, COP, PEN or ARS) and the calculation includes that currency risk.

How does it fit into a portfolio? What matters is not just its risk on its own, but how much it moves together with your other assets. Add it to your list and the optimizer will show you what weight the model would give it and why.

Other health care assets in Europe

Assets similar to argenx SE
Asset1 year1Y returnVolatilityMarket cap
Switzerland
Roche Holding AGROP.SW · Stock · Health Care
+43.5%24%US$378.1B
Switzerland
Novartis AGNOVN.SW · Stock · Health Care
+26.6%23%US$298.0B
United Kingdom
AstraZeneca PLCAZN.L · Stock · Health Care
+2.8%27%US$266.9B
United Kingdom
GSK plcGSK.L · Stock · Health Care
+14.9%25%US$101.6B
France
SanofiSAN.PA · Stock · Health Care
-9.7%22%US$99.9B
France
EssilorLuxottica Société anonymeEL.PA · Stock · Health Care
-42.3%33%US$90.1B
Switzerland
Lonza Group AGLONN.SW · Stock · Health Care
+13.6%23%US$53.4B
Switzerland
Galderma Group AGGALD.SW · Stock · Health Care
+37.7%29%US$52.9B

Disclaimer: Educational and simulation tool. It is not investment advice or a personalized recommendation. Past performance does not guarantee future results. Data for educational purposes; it may be delayed or contain errors.